Unique ID issued by UMIN | UMIN000025731 |
---|---|
Receipt number | R000029600 |
Scientific Title | Effects of oral appliance (SomnoDent) on sleep disordered breathing (SDB) and cardiac function in patients with heart failure (HF) |
Date of disclosure of the study information | 2017/02/01 |
Last modified on | 2021/07/25 22:17:34 |
Effects of oral appliance (SomnoDent) on sleep disordered breathing (SDB) and cardiac function in patients with heart failure (HF)
Effects of oral appliance (SomnoDent) on sleep disordered breathing (SDB) and cardiac function in patients with heart failure (HF)
Effects of oral appliance (SomnoDent) on sleep disordered breathing (SDB) and cardiac function in patients with heart failure (HF)
Effects of oral appliance (SomnoDent) on sleep disordered breathing (SDB) and cardiac function in patients with heart failure (HF)
Japan |
Heart failure (HF)
Sleep disordered breathing (SDB)
Cardiology |
Others
NO
To investigate whether oral appliance (SomnoDent) can effectively suppress SDB in patients with HF, and whether suppression of SDB by oral appliance (SomnoDent) can improve cardiac function.
Efficacy
AHI or E/e' by echocardiogram (tissue Doppler image) or plasma BNP level at 3 months
Interventional
Parallel
Randomized
Cluster
Open -but assessor(s) are blinded
Placebo
2
Treatment
Device,equipment |
SomnoDent (Intervention)
for 3 months, over 4 hours/day
Placebo (Control)
for 3 months, over 4 hours/day
20 | years-old | <= |
Not applicable |
Male and Female
1) Patients with symptomatic chronic HF (HF diagnosis and on beta blockers over 3 months, No change in HF drugs within 2 weeks)
2) New York Heart Association (NYHA) functional class is greater than or equal to II; either heart failure with reduced ejection fraction (left ventricular ejection fraction is less than or equal to 50%) or heart failure with preserved ejection fraction (history of hospitalization due to acute decompensated heart failure or plasma BNP level is greater than or equal to 100 pg/mL)
3) coexisting SDB (AHI is greater than or equal to 10 and the percentage of central AHI per total AHI is less than or equal to 70%)
1) Primary valvular heart disease
2) PCI or TAVI or cardiac surgery within 3 months
30
1st name | Takatoshi |
Middle name | |
Last name | Kasai |
Juntendo University School of Medicine
Department of Cardiovascular Medicine, Cardiovascular Respiratory Sleep Medicine
113-8421
2-1-1 Hongo, Bunkyoku, Tokyo
03-3813-3111
kasai-t@mx6.nisiq.net
1st name | Takatoshi |
Middle name | |
Last name | Kasai |
Juntendo University School of Medicine
Department of Cardiovascular Medicine, Cardiovascular Respiratory Sleep Medicine
113-8421
2-1-1 Hongo, Bunkyoku, Tokyo
03-3813-3111
kasai-t@mx6.nisiq.net
Juntendo University Hospital
SomnoMed Japan
Other
Toranomon Hospital (Devision of Cardiology, Sleep clinic)
Juntendo University Hospital IRB
2-1-1 Hongo, Bunkyoku, Tokyo
03-5802-1584
kenkyu5858@juntendo.ac.jp
NO
2017 | Year | 02 | Month | 01 | Day |
Unpublished
Terminated
2016 | Year | 12 | Month | 19 | Day |
2016 | Year | 12 | Month | 19 | Day |
2017 | Year | 04 | Month | 01 | Day |
2019 | Year | 03 | Month | 31 | Day |
2017 | Year | 01 | Month | 18 | Day |
2021 | Year | 07 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029600